Michael R. Megna

Insider Reports History

Entity
Individual
Location
1050 Hingham Street, Rockland, MA
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael R. Megna:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Class A Ordinary Share 32.5K $660K $20.28 Apr 7, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Share Option 21.2K Apr 1, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Performance Share Option 5.46K May 1, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Restricted Share Unit 3.93K Apr 7, 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Performance Share Unit 3.43K May 1, 2025 Direct

Insider Reports Filed by Michael R. Megna

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals International, plc May 1, 2025 4 $0 4 May 5, 2025 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 7, 2025 3 -$33.8K 4 Apr 9, 2025 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Apr 1, 2025 8 -$45.4K 4 Apr 3, 2025 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Mar 16, 2025 4 $87.90 4 Mar 19, 2025 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Mar 12, 2025 3 -$103K 4 Mar 14, 2025 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Nov 27, 2024 6 -$98.1K 4 Dec 2, 2024 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Oct 4, 2024 3 -$2.01K 4 Oct 8, 2024 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals International, plc Jul 15, 2024 10 -$75K 4 Sep 4, 2024 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 4, 2024 5 -$29.8K 4 Apr 8, 2024 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2024 3 -$21.4K 4 Apr 3, 2024 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Feb 28, 2024 9 -$161K 4 Mar 1, 2024 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jan 2, 2024 3 -$88.2K 4 Jan 4, 2024 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Dec 19, 2023 3 -$48.9K 4 Dec 21, 2023 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Oct 4, 2023 3 -$833 4 Oct 6, 2023 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jul 15, 2023 9 -$17.4K 4 Sep 6, 2023 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 10, 2023 3 -$12.4K 4 Apr 11, 2023 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2023 2 $0 4 Apr 3, 2023 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jan 15, 2023 7 -$2.86K 4 Mar 20, 2023 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Oct 4, 2022 3 -$740 4 Oct 6, 2022 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 1, 2022 6 $4.11K 4 Sep 6, 2022 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 7, 2022 2 $0 4 Apr 11, 2022 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 21, 2022 3 -$12.3K 4 Mar 23, 2022 CHIEF ACCOUNTING OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Oct 4, 2021 1 $0 4 Oct 6, 2021 Chief Accounting Officer
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 2, 2021 2 $0 4 Sep 7, 2021 Chief Accounting Officer
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 30, 2020 7 $22.5K 4 Mar 18, 2022 Chief Accounting Officer